Eliezer Masliah

Eliezer Masliah in 2016 Eliezer Masliah (born ) is a neuropathologist who was the director of the division of neuroscience at the National Institute on Aging from 2016 to 2024. In September 2024, an investigation exposed image manipulation across 132 of Masliah's research papers, raising concerns about data integrity in studies influencing Alzheimer's and Parkinson's disease treatments, pharmaceutical patents, and clinical trials. As of March 2025 he has 4 retractions. Provided by Wikipedia
Showing 1 - 3 results of 3 for search 'Eliezer Masliah', query time: 0.01s Refine Results
  1. 1
    Therapeutic Potential of α-Synuclein Evolvability for Autosomal Recessive Parkinson’s Disease

    Therapeutic Potential of α-Synuclein Evolvability for Autosomal Recessive Parkinson’s Disease by Jianshe Wei, Gilbert Ho, Yoshiki Takamatsu, Eliezer Masliah, Makoto Hashimoto

    Published 2021-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer’s disease model

    Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer’s disease model by Jiqing Xu, Fred de Winter, Catherine Farrokhi, Edward Rockenstein, Michael Mante, Anthony Adame, Jonathan Cook, Xin Jin, Eliezer Masliah, Kuo-Fen Lee

    Published 2016-08-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Author Correction: Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer’s disease model

    Author Correction: Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer’s disease model by Jiqing Xu, Fred de Winter, Catherine Farrokhi, Edward Rockenstein, Michael Mante, Anthony Adame, Jonathan Cook, Xin Jin, Eliezer Masliah, Kuo-Fen Lee

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: